4/24
11:47 am
cmrx
Glioma Pipeline Landscape Report 2024: Comprehensive Market Insights on 180+ Companies and Respective 200+ Pipeline Drugs [Yahoo! Finance]
Low
Report
Glioma Pipeline Landscape Report 2024: Comprehensive Market Insights on 180+ Companies and Respective 200+ Pipeline Drugs [Yahoo! Finance]
4/24
07:10 am
cmrx
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024 [Yahoo! Finance]
Medium
Report
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024 [Yahoo! Finance]
4/24
07:00 am
cmrx
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
Medium
Report
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
4/16
04:29 pm
cmrx
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
4/16
04:05 pm
cmrx
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/15
06:33 am
cmrx
We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Medium
Report
We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully [Yahoo! Finance]
3/21
07:17 am
cmrx
Chimerix Appoints Marc D. Kozin to Board of Directors [Yahoo! Finance]
Low
Report
Chimerix Appoints Marc D. Kozin to Board of Directors [Yahoo! Finance]
3/21
07:00 am
cmrx
Chimerix Appoints Marc D. Kozin to Board of Directors
Medium
Report
Chimerix Appoints Marc D. Kozin to Board of Directors
3/5
08:50 am
cmrx
Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Medium
Report
Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
3/4
11:05 pm
cmrx
Chimerix, Inc. (NASDAQ: CMRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Chimerix, Inc. (NASDAQ: CMRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/1
09:18 am
cmrx
Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/1
08:14 am
cmrx
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Medium
Report
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
2/29
08:27 am
cmrx
Chimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Chimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
2/29
07:23 am
cmrx
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update [Yahoo! Finance]
Medium
Report
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update [Yahoo! Finance]
2/29
07:00 am
cmrx
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
Medium
Report
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
2/27
07:00 am
cmrx
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
Low
Report
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
2/22
07:02 am
cmrx
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024 [Yahoo! Finance]
Low
Report
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024 [Yahoo! Finance]
2/22
07:00 am
cmrx
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
Low
Report
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
2/18
07:26 am
cmrx
Chimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutions [Yahoo! Finance]
Medium
Report
Chimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutions [Yahoo! Finance]
2/12
06:18 pm
cmrx
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Medium
Report
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.